NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Health Research Institutes, Taiwan
University Hospital, Essen
Sun Yat-sen University
Fudan University
University of Cologne
The First Affiliated Hospital of Zhengzhou University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Case Comprehensive Cancer Center
Jiangsu Cancer Institute & Hospital
Kidney Cancer Research Bureau
Sun Yat-sen University
Uppsala University
Ruijin Hospital
National Cheng-Kung University Hospital
Ludwig-Maximilians - University of Munich
Hospital Israelita Albert Einstein
Second Affiliated Hospital, School of Medicine, Zhejiang University
GERCOR - Multidisciplinary Oncology Cooperative Group
Jinling Hospital, China
Fujian Medical University Union Hospital
Changhai Hospital
Sun Yat-sen University
Catharina Ziekenhuis Eindhoven
Federation Francophone de Cancerologie Digestive
Shandong Cancer Hospital and Institute
Fudan University
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
Sichuan University
Nanfang Hospital, Southern Medical University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Salah Azaïz Cancer Institute
Sun Yat-sen University
University of Roma La Sapienza
Yixing People's Hospital
The First Affiliated Hospital of Zhengzhou University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Xijing Hospital
Xijing Hospital
National Cancer Institute, Naples
Liaoning Cancer Hospital & Institute
Zhujiang Hospital
Zhujiang Hospital
Sixth Affiliated Hospital, Sun Yat-sen University
Fudan University
Zhejiang University
Fudan University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology